Parkinsons Flashcards

1
Q

What is the difference between L-DOPA and dopamine?

A

L-dopa is a dopamine pre-cursor that can cross the blood brain barrier, and be converted by DOPA decarboxylase to dopamine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How much oral L-DOPA reaches the brain?

A

1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a contraindication for L-DOPA?

A

Closed angle glaucoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Where does L-DOPA need to replenish dopamine in order to control parkinsons symptoms?

A

The neostriatum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are ADRs of L-DOPA, MAOIs and Dopamine Receptor Agonists?

A

Schizophrenic-type psychosis symptoms, hypotension, dyskinesia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the oral bioavailability of L-DOPA?

A

10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is a DDI of L-DOPA?

A

Vitamin B6, which incrases peripheral L-DOPA breakdown.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What drugs are given with L-DOPA?

A

Sinemet or madopar, which are peripheral DOPA decarboxylase inhibitors which decrease ADRs and increase effectiveness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Name 3 examples of oral Dopamine Receptor Agonists

A

Bromocriptine, Ropinirole and Pergolide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Name an example of a sub-cutaneous Dopamine Receptor Agonist

A

Apomorphine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the mechanism of action of Dopamine Receptor Agonists?

A

Bind and agonise D2 dopamine receptors in the neostriatum.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Name a Monoamine Oxidase Type B Inhibitor used in treatment of Parkinsons

A

Selegiline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does selegiline work?

A

Inhibits MAOb enzyme which breaksdown dopamine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Name a Catechol-o-methyl Transferase Inhibitor and state when it would be used

A

Entacapone, and used to as an L-DOPA adjuvant to lower the required dose of L-DOPA and decrease it’s ADRs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Name 2 common ADRs of Catechol-o-Methyl Transferase Inhibitors

A

Abdominal pain and diarrhoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is a contraindication of entacapone use?

A

Phaeochromocytoma

17
Q

How does entacapone work?

A

Inhibits Catechol-O-Methyl Transferase, which is an enzyme that breaks down dopamine.

18
Q

Name some anticholinergics used in Parkinsons treatment

A

Benzatropine, Procyclidine, Orphenadrine

19
Q

How do anticholinergics reduce Parkinsons symptoms?

A

Antagonise muscarinic receptors which are responsible for mediating striatum cholinergic excitation/activity.

20
Q

What are ADRs of anticholinergics?

A

Memory loss, episodes of acute confusion, dry mouth and blurred vision.

21
Q

What will happen if anticholinergics are rapidly withheld?

A

Worsening of Parkinsons

22
Q

How does Amantidine work?

A

Stimulates neuronal dopamine release and inhibits it’s reuptake, as well as having some mild muscarinic antagonism, reducing striatum cholinergic activity.

23
Q

What are some ADRs of Amantidine?

A

Anorexia, nausea and hallucinations.

24
Q

How long is amantidine effective for in reducing Parkinsons symptoms?

A

6 months